COXAPRIN QUIZ

What makes Polmacoxib different from traditional NSAIDs?

• It inhibits both COX-1 and COX-2

• It selectively inhibits COX-2 in joint tissues only

• It blocks all inflammatory pathways

• It has no effect on COX enzymes

Why do traditional COX-2 inhibitors (like Etoricoxib) have a black box warning?

• They cause severe gastrointestinal bleeding

• They increase the risk of heart attacks and strokes
  
  

• They have poor efficacy in pain relief
  
  

• They are not widely prescribed

What is the key advantage of Polmacoxib over Etoricoxib?

• Lower price
  
  

• Stronger anti-inflammatory effect

• Better cardiovascular safety

• Faster pain relief

Who are the Primary Target (A) doctors for Coxaprin?

• Doctors who already prescribe Polmacoxib

• Doctors prescribing Diclofenac and Aceclofenac

• Doctors unaware of Polmacoxib but using Etoricoxib

• Pediatricians treating inflammation

Why are physicians managing diabetes and hypertension a key target for Coxaprin?

• They frequently prescribe Diclofenac

• They have a low patient load

• They need safer NSAIDs due to cardiovascular risks

• They prescribe only Etoricoxib for pain relief

What is the recommended visit frequency per doctor for effective Coxaprin promotion?

• Once a month
  
  

• Twice a month

• Weekly (4 times a month)
  
  

• Daily

What is the total number of targeted doctors per representative for Coxaprin?

• 10

• 20

• 30

• 40

What is the punchline of Coxaprin?

• Targeted Relief, Maximum Safety

• Smart COX-2 Inhibitor with the Principle of Safety

• Precision in Pain Management

• Beyond NSAIDs – A Step Ahead

What is the tagline of Coxaprin?

• Smart COX-2 Inhibitor with the Principle of Safety

• Precision in Pain Management

• A Next-Gen Tissue-Selective COX-2 Inhibitor Designed for Efficacy and Safety

• The Future of Pain Relief

·         What is the MRP of Coxaprin (Polmacoxib 2mg) per tablet?

•   ₹16.50

•    ₹17.90

• ₹16.90

•     ₹18.50